Storia in 3 fonti

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO entered its final bidding day with strong demand, with the Rs 939.70-crore issue subscribed 4.91 times. Its GMP has risen to 17.1%, signalling expectations of a strong listing. The IPO comprises a Rs 200-crore fresh issue and a Rs 739.70-crore OFS.

Raccontata da

economictimes.indiatimes.com

thehindubusinessline.com

m.economictimes.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

economictimes.indiatimes.comStai leggendo2 g fa

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO raises Rs 939.70 crore (4.91x oversubscribed, 17% GMP) on Truenat portable molecular diagnostics platform. 42% YoY revenue growth (Rs 1.5B) and proprietary point-of-care device demonstrate global scaling; IPO capital funds R&D and manufacturing expansion.

originale

m.economictimes.com5 g fa

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics valuations are broadly in line with industry benchmarks. The company is also being offered at a discount to the average P/E…

Timeline cronologica

domenica 9 agosto 2026·economictimes.indiatimes.com
World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round
Molbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 crore IPO opening on August 10. The…
lunedì 10 agosto 2026·economictimes.indiatimes.com
Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?
Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm intends to reduce promoter stake by…

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Confronto fonti

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Timeline cronologica

World Bank's IFC, HDFC AMC invest in Molbio Diagnostics' Rs 281 crore IPO anchor round

Can Molbio Diagnostics IPO deliver long-term growth for high risk investors?

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day

Molbio Diagnostics IPO: Analyst recommendations—should you subscribe or give it a miss?

Molbio Diagnostics IPO opens today: GMP at 15% — Check price band. Should you subscribe?

Molbio Diagnostics IPO opens: Should you subscribe for Rs 940 crore issue?

Molbio IPO Day 2: GMP hits at 17% listing gains. Should you bid?

Screening India’s healthcare diagnostics market

Molbio Diagnostics IPO Day 3: GMP hints at 17% listing gain, issue booked nearly 5x. Should you participate?

Dhoot Transmission, Molbio Diagnostics IPOs see over 70 times subscription on closing day

Molbio Diagnostics IPO allotment likely today; GMP at 20% — Here’s how to check status